• Citer

KRAS G>A mutation favors poor tumor differentiation but may not be associated with prognosis in patients with curatively resected duodenal adenocarcinoma.

par Fu, Tao;Guzzetta, Angela AA;Jeschke, Jana ;Vatapalli, Rajita;Dave, Pujan;Hooker, Craig M;Morgan, Richard;Iacobuzio-Donahue, Christine A;Liu, Baohua;Ahuja, Nita
Référence International journal of cancer, 132, 11, page (2502-2509)
Publication Publié, 2013-06

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	KRAS G>A mutation favors poor tumor differentiation but may not be associated with prognosis in patients with curatively resected duodenal adenocarcinoma.
Auteur:	Fu, Tao; Guzzetta, Angela AA; Jeschke, Jana; Vatapalli, Rajita; Dave, Pujan; Hooker, Craig M; Morgan, Richard; Iacobuzio-Donahue, Christine A; Liu, Baohua; Ahuja, Nita
Informations sur la publication:	International journal of cancer, 132, 11, page (2502-2509)
Statut de publication:	Publié, 2013-06
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adenocarcinoma -- genetics -- mortality -- pathology -- surgery
	Biomarkers, Tumor -- genetics
	Cell Differentiation
	DNA, Neoplasm
	Duodenal Neoplasms -- genetics -- mortality -- pathology -- surgery
	Female
	Humans
	Male
	Microsatellite Repeats
	Middle Aged
	Mutation -- genetics
	Neoplasm Recurrence, Local -- genetics -- mortality -- pathology -- surgery
	Neoplasm Staging
	Polymerase Chain Reaction
	Prognosis
	Proto-Oncogene Proteins -- genetics
	Proto-Oncogene Proteins p21(ras)
	Survival Rate
	ras Proteins -- genetics
Langue:	Anglais
Identificateurs:	urn:issn:0020-7136
	info:doi/10.1002/ijc.27910
	info:pmid/23065691
	PMC3579006